Share & Corporate Information
Share & Corporate Information
SHARE INFORMATION
|
|
| Date of Listing |
8 / 11 / 2017
|
| Number of Listed Shares |
1,120,000,000 |
| Par Value / Share |
0.25 EGP (twenty five piasters)
|
| Authorized Capital |
1,000,000,000 EGP (one billion Egyptian Pounds)
|
| Issued Capital |
280,000,000 EGP (two hundred and eighty million Egyptian Pounds) |
| Paid-Up Capital |
280,000,000 EGP (two hundred and eighty million Egyptian Pounds) |
SHAREHOLDER STRUCTURE
Ibnsina Pharma’s shareholders include prominent members of the Egyptian business community and large institutional shareholders that have allowed the company to significantly enhance its corporate governance practices and systems. The company’s shareholders include the Mahgoub family (13.0%), the Abdel Gawad family (13.5%), the European Bank for Reconstruction and Development (EBRD) (8.7%), and Faisal Islamic Bank (12.6%). Other shareholders, including members of its senior management team, collectively (5.2%), treasury (10.0%), and free float (37.4%).
| Shareholder |
% |
| Treasury |
10.00 |
| Senior Management Team |
5.20 |
| Free Float |
37.00 |
| Faisal Islamic Bank |
12.60 |
| EBRD |
8.70 |
| Mahgoub Family |
13.00 |
| Abdel Gawad & Family |
13.50 |
Corporate Information
|
|
| Year Founded |
2001 |
| Commercial Registration Number |
Commercial Registration number 10724 dated 28/8/2017 Commercial Registry Office, Cairo
|
| Fiscal Year |
1 January - 31 December
|
| Law of Governance |
Law (159) 1981
|
| Auditor Name |
Khaled El Ghannam, Eissa Refai & Co. |
| Headquarters |
Obour City, Industrial Zone 1, Block 12015, Egypt
|
